Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139605/0/en/Immuneering-Announces-Closing-of-25-Million-Private-Placement.html
25 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/25/3138395/0/en/Immuneering-Announces-Clinical-Supply-Agreement-with-Lilly-to-Evaluate-Atebimetinib-in-Combination-with-Olomorasib.html
21 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/21/3137065/0/en/Immuneering-Announces-25-Million-Private-Placement.html
13 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/13/3132969/0/en/Immuneering-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112517/0/en/Immuneering-Granted-U-S-Composition-of-Matter-Patent-for-Highly-Differentiated-Cancer-Drug-Candidate-Atebimetinib.html
17 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/immuneering-sees-94-survival-6-months-pancreatic-cancer-teeing-pivotal-trial-plans
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE